2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
449
Stomach Neoplasms
295
Rectal Neoplasms
271
Colonic Neoplasms
192
Pancreatic Neoplasms
175
Neoplasm Metastasis
110
Esophageal Neoplasms
88
Neoplasms
68
Carcinoma, Hepatocellular
60
Adenocarcinoma Of Esophagus
47
Adenocarcinoma
46
Cholangiocarcinoma
45
Lymphoma, Large B-Cell, Diffuse
44
Carcinoma, Non-Small-Cell Lung
41
Biliary Tract Neoplasms
38
Gallbladder Neoplasms
31
Gastrointestinal Neoplasms
29
Recurrence
25
Liver Neoplasms
25
Ovarian Neoplasms
23
Esophageal Squamous Cell Carcinoma
23
Breast Neoplasms
22
Peritoneal Neoplasms
18
Bile Duct Neoplasms
17
Unspecified Adult Solid Tumor, Protocol Specific
16
Parkinson Disease 4, Autosomal Dominant Lewy Body
14
Locally Advanced Rectal Cancer
13
Head and Neck Neoplasms
13
Lung Neoplasms
12
Lymphoma, Non-Hodgkin
11
Interventions
Radiotherapy
38
Radiotherapy, Intensity-Modulated
12
Cisplatin
12
Amifostine
11
Paclitaxel
7
Carboplatin
7
Radiosurgery
6
Etoposide
5
Brachytherapy
5
Surgical Procedures, Operative
4
Low-Level Light Therapy
4
Donepezil
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sargramostim
3
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Neuropsychological Tests
3
Mental Status and Dementia Tests
3
Magnetic Resonance Spectroscopy
3
Heavy Ion Radiotherapy
3
Filgrastim
3
Diet Therapy
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Radiotherapy, Conformal
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Lithium
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radiation Injuries
×
Oxaliplatin
×
Clear all
NCT02121405
2022-05-11
PSSR
Zhejiang University
Phase 3
Suspended
350 enrolled